Comments
Dr Reddy’s Laboratories Ltd has announced the launch of Lansoprazole DR orally disintegrating tablets, a therapeutic equivalent generic version of Prevacid SoluTab delayed-release orally disintegrating tablets, 15 mg and 30 mg, approved by the US Food and Drug Administration (USFDA).
Also read: Dr Reddy’s Labs launches Capecitabine tablets in US market
The Prevacid brand and generic had US sales of approximately $87 million MAT for the most recent 12 months ending in December 2020, according to IMS Health.
Dr Reddy’s Lansoprazole DR orally disintegrating tablets are available in 15 mg and 30 mg tablets in unit-dose packages of 100 (10 x 10), according to a statement.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.